Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma. Hematology Meeting Reports, [S. l.], v. 2, n. 13, 2009. DOI: 10.4081/hmr.v2i13.485. Disponível em: https://journals.pagepress.net/hmr/article/view/485. Acesso em: 28 may. 2026.